Sangsangin Ian No.1 Special Purpose Acquisition Co. Ltd (KQ:307870) — Market Cap & Net Worth
Market Cap & Net Worth: Sangsangin Ian No.1 Special Purpose Acquisition Co. Ltd (307870)
Sangsangin Ian No.1 Special Purpose Acquisition Co. Ltd (KQ:307870) has a market capitalization of $46.58 Million (₩68.73 Billion) as of July 14, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #22172 globally and #1347 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sangsangin Ian No.1 Special Purpose Acquisition Co. Ltd's stock price ₩925.00 by its total outstanding shares 74299285 (74.30 Million). See Sangsangin Ian No.1 Special Purpose Acqu (307870) capital reinvestment to understand how much of operating cash flow is reinvested back into capital assets.
Sangsangin Ian No.1 Special Purpose Acquisition Co. Ltd Market Cap History: 2026 to 2026
Sangsangin Ian No.1 Special Purpose Acquisition Co. Ltd's market capitalization history from 2026 to 2026. Data shows growth from $46.58 Million to $46.58 Million (0.00% CAGR).
Index Memberships
Sangsangin Ian No.1 Special Purpose Acquisition Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$224.31 Billion | 0.02% | #633 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$224.31 Billion | 0.02% | #633 of 1384 |
Weight: Sangsangin Ian No.1 Special Purpose Acquisition Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Sangsangin Ian No.1 Special Purpose Acquisition Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sangsangin Ian No.1 Special Purpose Acquisition Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 307870 by Market Capitalization
Companies near Sangsangin Ian No.1 Special Purpose Acquisition Co. Ltd in the global market cap rankings as of July 14, 2026.
Key companies related to Sangsangin Ian No.1 Special Purpose Acquisition Co. Ltd by market ranking:
- Twenty One Capital, Inc. (NYSE:XXI): Ranked #6568 globally with a market cap of $1.77 Billion USD.
- Drugs Made In America Acquisition II Corp. Ordinary Shares (NASDAQ:DMII): Ranked #10927 globally with a market cap of $642.73 Million USD.
- Ares Acquisition Corporation II (NYSE:AACT): Ranked #11364 globally with a market cap of $587.05 Million USD.
- Churchill Capital Corp XI (NASDAQ:CCXI): Ranked #11529 globally with a market cap of $568.14 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #6568 | Twenty One Capital, Inc. | NYSE:XXI | $1.77 Billion | $5.12 |
| #10927 | Drugs Made In America Acquisition II Corp. Ordinary Shares | NASDAQ:DMII | $642.73 Million | $10.09 |
| #11364 | Ares Acquisition Corporation II | NYSE:AACT | $587.05 Million | $9.49 |
| #11529 | Churchill Capital Corp XI | NASDAQ:CCXI | $568.14 Million | $14.34 |
Sangsangin Ian No.1 Special Purpose Acquisition Co. Ltd Historical Marketcap From 2026 to 2026
Between 2026 and today, Sangsangin Ian No.1 Special Purpose Acquisition Co. Ltd's market cap moved from $46.58 Million to $ 46.58 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩46.58 Million | -- |
End of Day Market Cap According to Different Sources
On Jul 14th, 2026 the market cap of Sangsangin Ian No.1 Special Purpose Acquisition Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $46.58 Million USD |
| MoneyControl | $46.58 Million USD |
| MarketWatch | $46.58 Million USD |
| marketcap.company | $46.58 Million USD |
| Reuters | $46.58 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sangsangin Ian No.1 Special Purpose Acquisition Co. Ltd
B2En Co., Ltd. provides data-related professional consulting, solutions, and system integration-related services in South Korea. The company was founded in 2004 and is headquartered in Seoul, South Korea.